Reason for request
Assessment of the dosage change permitting use in children.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
The medicinal product SMOFLIPID has the same actual benefit in the paediatric population as previously recognised by the transparency Committee in adults (IAB V). |
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
kGq5pTuwbzW7DajG
